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Available online 2 March 2016Background: Q waves and negative T waves are common electrocardiographic (ECG) abnormalities in patients
with Hypertrophic Cardiomyopathy (HCM). Several studies correlated ECG ﬁndings with presence and extent
of ﬁbrosis and hypertrophy; however, their signiﬁcance remains incompletely clariﬁed. Our study aimed to ex-
plain themechanism behind Q and negative Twaves by comparing their positions on a 12-lead ECGwith pheno-
types observed at Late Gadolinium Enhancement (LGE) Cardiac Magnetic Resonance (CMR).
Methods: 12-lead ECG and LGE-CMR were performed in 88 consecutive patients with HCM (42 SD 16 years, 65
males). Using Delta Thickness ratio (DT ratio), and “global” and “parietal” LGE at CMR, the extent and distribution
of myocardial hypertrophy and ﬁbrosis were studied in correlation with ECG abnormalities.
Results:Qwaves in different leads were not associatedwith “parietal” LGE score. Lateral Q waves correlated with
an increasedDT ratio Inferior Septum/Lateralwall (p=0.01). A similar correlation between inferior Qwaves and
an increased DT Ratio Anterior wall/Inferior wall was of borderline statistical signiﬁcance (p=0.06). As expect-
ed, ECG signs of LV hypertrophy related to a raised Left Ventricular Mass Index (LVMI) (p b 0.0001) and mean
wall thickness (p=0.01). Depolarization disturbances, including negative Twaves in lateral (p=0.044) and an-
terior (p= 0.031) leads correlated with “parietal” LGE scores while QT dispersion (p= 0.0001) was associated
with “global” LGE score.
Conclusion: In HCMpatients, Qwaves are generated by asymmetric hypertrophy rather than bymyocardialﬁbro-
sis, while negative T waves result from local LGE distribution at CMR.




Cardiac Magnetic Resonance1. Background
Hypertrophic Cardiomyopathy (HCM) is a genetic disorder with ex-
tremely variablemorphologic, functional, and clinical features [1]. More
than 90% of HCM patients with evidence of the disease at echocardio-
gram show various abnormalities in the 12-lead ECG [2], including
pathological Q waves, signs of LV hypertrophy, and repolarization dis-
turbances such as negative T-wave [3–5]. The pathogenesis of the ECG
ﬁndings, however, remains unclear. Different studies have correlated
ECG abnormalities with different imaging tests, adding important





land Ltd. This is an open access articlAuthors have tried to explain the mechanism of these ECG ﬁndings
using low-deﬁnition and two-dimensional imaging investigations,
such echocardiography and left ventriculogram, with controversial
results [3,4,6]. Late Gadolinium Enhancement Cardiac Magnetic
Resonance (LGE-CMR) however, offers high spatial resolution and 3-
dimensional tomographic imaging allowing not only for a more accu-
rate morphologic and functional deﬁnition of the left ventricle (LV),
but also giving information regarding tissue composition and revealing
areas of myocardial ﬁbrosis [7–11]. However: Q waves have not been
unequivocally correlated yet to a speciﬁc phenotype pattern. The hy-
pothesis that an asymmetric distribution of myocardial hypertrophy
rather thanmyocardial ﬁbrosismay generate Qwaves has been veriﬁed
in anterior leads but it has not been veriﬁed in other LV walls. In addi-
tion, negative T waves have been so far correlated with apical hypertro-
phy while their association with local distribution of LGE at CMR
appears to be relevant and needs to be supported more. The aim of
the present study is to verify the hypothesis that in patients with
HCM, Q waves are generated by asymmetric distribution of myocardiale under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Clinical features and risk factors.
Clinical features and risk factors N (%)
Age (years) 42 ± 16
Male 65 (74%)
Functional class NYHA I–II 80 (91%)
Family history of SCD 31 (25%)
Cardiac arrest or SVT 3 (3%)
NSVT 25 (28%)
Loss of consciousness 1 (1%)
Abnormal BP response during exercise 3 (3%)
Familial history of HCM 9 (10%)
High-risk genetic mutation 2 (2%)
LVT max N30 mm 8 (11%)
LVOTO 14 (16%)
SVT sustained ventricular tachycardia, SCD: Sudden Cardiac Death secondary to
HCM, NSTV: nonsustaintained ventricular tachycardia at 24-hour tape, BP: Blood
Pressure, HCM Hypertrophic Cardiomyopathy, LVT max N 30 mm: Left Ventricular
Thickness N30 mm at cardiac USS.




The initial study population included 137 consecutive patients with
Hypertrophic Cardiomyopathy (HCM) referred to our Centre between
October 2004 and January 2014. The diagnosis of HCM was based on
2-dimensional echocardiographic evidence of a hypertrophic left ven-
tricle (maximal wall thickness ≥ 15 mm in adult index patient or
≥13 mm in adult relatives of a HCM patient) in the absence of another
cardiac or systemic disease able to justify the amount of hypertrophy
observed (e.g hypertensive cardiopathy, athlete's heart, storage dis-
ease). Using this imaging techniquemaximal left ventricular wall thick-
ness (LVTmax)was initially assessed alongwith left ventricular outlow
tract obstruction (LVOTO), which was measured as instantaneous peak
Doppler LV outﬂow tract pressure gradient ≥30mmHg at rest or during
physiological provocation such as Valsalva manoeuvre. Forty-nine pa-
tients with a history of surgical myectomy, alcohol ablation, CMR con-
traindications (e.g pacemakers, implantable deﬁbrillators or atrial
ﬁbrillation), or with a poor quality ECG strip were excluded. Therefore
the ﬁnal study population included 88 patients.
A standard 12-lead ECGwas performed before CMR in all patients; it
was analysed by ECG analysis software (CALL ECG Version 2.6.5.) and
systematically reviewed by a single operator. The third universal deﬁni-
tion of myocardial infarction and modiﬁed Sokolow–Lyon criteria were
used to characterize pathological Q waves [12], and signs of LV hyper-
trophy [13]. Depolarization disturbances, including T wave inversion,
ST depression and QT dispersion, calculated as the difference between
minimum and maximum QT duration, were also noted.
Within 6months formclinical examination and 12-lead ECG, Cardiac
Magnetic Resonance images were obtained using a 1.5T scanner (Sie-
mens Synphony, Erlangen, Germany) with a phased array cardiac coil
and electrocardiogram gating. Cine magnetic resonance images were
acquired to assess ventricular function, using a segmented, balanced,
steady-state free precession sequence (b-SSFP) in three long-axis
planes and sequential 8 mm short-axis slices from the atrio-
ventricular ring to apex. On the latter axis LV endocardial and epicardial
borders were manually traced at end diastole and end systole respec-
tively. Other parameters were also measured, including LV mass, end-
diastolic (LVEDV), end-systolic (LVESV) volumes divided by body sur-
face area (BSA), as well as ejection fraction (LVEF). All CMR images
were analysed by validated software (Argus; Siemens Medical Solu-
tions) and reviewed by experienced radiologist and cardiologist. A 17-
segment model for the LV was used to assess extent and distribution
pattern of both end-diastolic wall thickness and LGE [14]. In regards
with the hypertrophic features of the LV, the short axis was used to
measure end-diastolic wall thickness of 16 segments while long axis
was used for the apex. All 17 thickness valuesweremarked and then av-
eraged to obtain an absolute value of maximal left ventricular thickness
(LVT max) as well as the mean end-diastolic thickness (mean DT). A
Delta Thickness ratio (DT ratio)was created to assess LV asymmetric hy-
pertrophy. This was expressed as ratio between the end-diastolic thick-
ness of a hypertrophied wall, including basal, mid and apical segments,
and its opposite wall. In particular, a DT ratio between Inferior Septum/
and Lateral wall (DT ratio Sep-lat), anterior/inferior wall (DT ratio ant-
inf) and inferior/anterior wall (DT ratio inf-ant) was calculated. Then
0.2 mmol/kg of Gadolinium-DTPA (Gadovist; Bayer Schering Pharma,
Berlin, Germany or Magnevist, SheringPharma, Germany) was injected,
and 10–15min later LGE images were obtained with a breath-hold 2-D
segmented phase sensitive inversion-recovery sequence (inversion
time between 240 and 300 ms). LGE was considered present in areas
with signal intensity exceeding 5 standard deviation (SD) compared
to normal myocardium signal. The amount of LGE was measured by asemi-quantitative method, using a visual score post-processed by soft-
ware CMR42 (Circle Cardiovascular Imaging, Calgary, Alberta, Canada)
and blindly assessed by 2 different and expert operators. Each segment
was scored out of three (1 if LGE involved b25%, 2 if between 25% and
50%, and 3 if more than 50% of the wall thickness) and a “parietal” and
“global” LGE scores were calculated as the sum of the visual scores of
basal, mid and apical segments of a given wall and the whole ventricle.
Data were analysed using the software STATA 13.1 (STATA Corpora-
tion College Station, Tx, USA). Continuous variables were expressed as
median and interquartile range and analysed with the Mann–Whitney
U test; categorical variables were expressed as a percentage and com-
pared by Fisher's exact test. The association between continuous vari-
ables was analysed using Pearson's coefﬁcient R or Spearman's
coefﬁcient R, depending on the distribution, with their associated CI at
95%. A two-tailed p value of b0.05 was considered statistically signiﬁ-
cant. All participants provided written informed consents.3. Results
Clinical characteristics and risk factors are detailed in Table 1. The
study population consisted of 88 patients, 65 males (74%) and 23 fe-
males (26%), aged between 8 and 76 years old (mean age 42 SD
16 years). Fifty-seven patients (65%) were in New York Heart Associa-
tion functional class I (NYHA I), 23 patients (26%) in NYHA II, 8 patients
(16%) in NYHA III. Only 14 patients showed signs of subvalvular ob-
struction with an intraventricular gradient N30 mmHg at continuous-
Doppler placed on the LVTOT during the echocardiogram study.
Thirty-one patients had a familial history of HCM (FHHCM), while 8 pa-
tients (11%) was found to have a LVT max N30 mm at USS.
Only 2 patients (2%) had a normal ECG, while the other 86 (98%)
showed different ECG abnormalities. The presence of negative T waves
on ECG was by far the most common ECG abnormality detected (89%),
while signs of LVhypertrophy andpathological Qwaves [12] in different
leadswere found in 51% and 38% of cases respectively. Other electrocar-
diographic abnormalities are listed in detail in Table 2.
Morpho-functional data were obtained from a systematic review of
CMR images (Table 3). In detail, the mean wall thickness was 11.2 SD
2.9 mm, the mean value for the maximum thickness was 23 SD
7.5 mm, and the LV Mass Index (LVMI) was 94.2 SD 42.7 g/m2.
Seventy-eight patients (88%) had features of asymmetric LV hypertro-
phy either localised in the posterior septum, anterior or posterior wall,
with 13 patients (15%) had a LVTmax N30mmat CMR. Seventy-ﬁve pa-
tients (86%) showed different levels and patterns of LGE after paramag-
netic medium of contrast injection, with a mean “global” LGE score
above 10 (10.4 SD 9.9). Twenty-nine patients (33%) had parietal LGE
score N 1 in antero-Lateral wall (6th, 12th and 16th segments) while
Table 2
ECG features.
ECG features N (%)
Normal ECG 2 (2%)
Abnormal Q waves 33 (38%)
Inferior leads −18 (20%)
Lateral leads −11 (12%)
Anterior leads −5 (6%)
LBBB 2 (2%)
Signs of LV hypertrophy 45 (51%)
Negative T waves 79 (89%)
Antero-lateral leads −21 (23%)
Lateral leads −23 (26%)
Anterior leads −5 (6%)
ST depression 28 (31%)
Pathological Q waves: latest universal deﬁnition of Myocardial Infarc-
tion [16]; LBBB: Left Bundle Branch Block; Signs of LV hypertrophy:
Left ventricular Hypertrophy using modiﬁed Sokolow–Lyon criteria,
ST depression: depression ST segment N1 mm at 80 msec from J point.
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15th segments).
Two patientswere excluded from theQwave analysis since showing
LBBB features on ECG. It was also decided not to analyse the anterior
wall since only few patients showed pathological Q waves in the anteri-
or leads (n = 5). Pathological Q waves in both lateral (1.3 SD 2.06 vs
1.13 SD 2.01, p = 0.81) and inferior leads (0.88 SD 2.31 vs 1.36 SD
2.12, p= 0.42) did not correlate with the “parietal” LGE score of lateral
and inferior walls, calculated as the sum of the LGE score of the 3 corre-
spondent segments. However, pathological Q waves in the lateral leads
correlated with DT Ratio Inferior Septum–Lateral wall (1.62 SD 0.46 vs
1.34 SD 0.39, p=0.01) and an association betweenQwaves in the infe-
rior leads and a DT ratio anterior wall – inferior wall, approached statis-
tical signiﬁcance (1.5 SD 0.64 vs 1.21 SD 0.45, p = 0.06) (Fig. 1). No
signiﬁcant correlation was noted (p = 0.6) between the presence of
LVT max N30 mm in any of the 17 segments and the presence of Q
waves on the ECG, with only 3 patients satisfying both criteria.
Using themodiﬁed Sokolow–Lyon criteria, half of the patients (51%)
showed ECG signs of LV hypertrophy, which, as expected, shared a lin-
ear relationship with both LVMI (r = 0.38, p b 0.0001) (Fig. 2) and
mean LV thickness (10.4 SD 2.5 n = 43 vs 12 SD 3.1 n = 45 p= 0.01)
(Fig. 3). Conversely, there was no correlation between ECG signs of LV
hypertrophy and LVT max thickness (p= 0.58).
Various repolarization disturbances were detected. First, negatives T
waveswere themost common abnormality (89%) amongHCMpatients.
The “parietal“LGE score for the anterior wall was signiﬁcantly higher in
patients with negative T waves in the anterior leads if compared with
patients without such ECG abnormality (3.08 SD 3.04 vs 1.82 SD 2.31,Table 3
CMR-LGE features.
CMR-LGE features
LVEDV/BSA (ml/m2) 80.2 SD 20
LVESV/BSA (ml/m2) 48.5 SD 12
LVEF (%) 62 SD 9.3
LVMI (g/m2) 94.2 SD 42.7
Mean thickness (mm) 11.2 SD 2.9
Patients with LVT max N30 mm (n) 13 (15%)
Mean max thickness (mm) 23 SD 7.5
Patients with LGE n (%) 75 (86%)
“Global” LGE score 10.4 SD 9.9
“Parietal” LGE score N 1
–In the 6th,12th,16th segments −29 (33%)
–In the 4th, 10th and 14th segments −51 (58%)
LVEDV: Left Ventricular End-Diastolic Volume, BSA: Body Surface Area, LVESV: Left Ven-
tricular End Sistolic Volume, LVEF: Left Ventricular Ejection Fraction, LVMI: Left Ventricu-
lar Myocardial Index, LVT max maximal Left Ventricular Thickness LGE Late Gadolinium
Enhancement.p= 0.044). Similarly, negative T waves in the lateral leads were more
common in patients with increased LGE score of the Lateral wall (1.33
SD 2.13 vs 0.46 SD 1.31, p= 0031). However correlation between infe-
rior negative T waves and increased LGE of the inferior wall was also
suggested,without attaining statistical signiﬁcance (p=0.089). Second,
ST segment depression was not correlated neither with LGE score
(11.14 SD 10.5 vs 10.1 SD 9.8, p= 0.6) or LVMI (103.2 SD 60.3 vs 89.8
SD 30.6, p = 0.2), but it was more common in patients showing ECG
signs of LV hypertrophy. Last, the QT dispersion was predicted by the
LGE score (β= 0.381, p= 0.0001), but was not related with LVMI.
4. Discussion
The main result of the present study is the contribution to a more
precise understanding of the exact pathogenesis of ECG abnormalities
in HCM patients. In particular our data strongly support the hypothesis
that abnormal Qwaves result from imbalanced electrical forces generat-
ed by the asymmetric distribution of myocardial hypertrophy in oppo-
site left ventricular walls.
A direct correlation between increasing LVMI, LGE prevalence/ex-
tent at CMR and number/severity of ECG abnormalities has been previ-
ously observed and a simple score has been proposed for the
quantiﬁcation of the abnormal ECG ﬁndings in HCM patients, including
Q and negative T waves and other repolarisation disturbances [15]. The
pathophysiological mechanism causing abnormal Q waves is still object
of controversy. Some Authors previously suggested that abnormal Q
waves in HCMpatients are caused by the presence of ﬁbrotic tissue sim-
ilarly to transmuralmyocardial infarction [16,17]. Others, by correlating
ECG ﬁndings with echocardiogram ﬁrst and LGE-CMR later suggested
that lateral Q waves might be secondary to an abnormal activation of
thehypertrophied septumrather thanﬁbrosis [6,13,18]. This hypothesis
was also recently supported by a French study of 42 patients [19]. Neg-
ative T waves have been correlated with a speciﬁc pattern of apical hy-
pertrophy extremely common in Asia (25% of cases) called “Japanese
variant” ascribing the pathogenesis of such ECG abnormalities to a
chronic ischaemia and ﬁbrosis replacement [20].
With a sensible sample size, the present study aimed to conﬁrm the
hypothesis that focal distribution of myocardial hypertrophy and ﬁbro-
sis on LGE-CMR correlated with ECG abnormalities in the leads explor-
ing the very same LV walls.
First, a statistically signiﬁcant correlation between lateral Q waves
and DT ratio Inferior Septum–Lateral wall was noted, while Q waves
in inferior leads and DT ratio anterior-inferior wall had p-value just
above the signiﬁcance level (p = 0.06). This observation supports the
hypothesis that pathological Q waves observed in a given lead might
be the result of an unbalanced electrical-force generated by an asym-
metric hypertrophy of the ventricular wall opposite to the ECG explor-
ing lead, rather than by myocardial ﬁbrosis.
Second, as expected, signs of hypertrophy on ECG correlated with
both with LVMI and mean thickness, but not with maximum thickness
N30 mm.
Third, depolarization disturbances were found extremely common
and correlatedwith LGE. In fact, almost 90% of our patients showed neg-
ative T waves. When present in anterior and Lateral walls negative T
waves signiﬁcantly correlatedwith the “parietal” LGE score of the corre-
spondent walls. In regards with the inferior wall a correlation between
ECG and CMR ﬁndings was suggested, yet not statistically signiﬁcant.
Also, many Authors demonstrated QT dispersion is increased in patients
with HCM [21–23]. In our study, LGE score predicted the QT dispersion,
most likely due to the local difference of the repolarization duration, and
increasing the risk of malignant ventricular arrhythmias [22–24]. It is
likely that myocardial disarray and ﬁbrosis may result in heterogeneity
of the ventricular refractory period and intra-ventricular conduction,
causing negative T waves and QT dispersion.
We concluded that Q waves might be generated by asymmetric dis-
tribution of myocardial hypertrophy rather than by myocardial ﬁbrosis,
Fig. 1. Pathogenesis of Q waves in HCM patients. Based on our results, abnormal Q waves may be generated by an increased electrical force generated by hypertrophied LV wall
overpowering the electrical vector by its opposite wall nearest to the exploring lead. 1: basal anterior, 2: basal anteroseptal, 3: basal inferoseptal, 4: basal inferior, 5: basal inferolateral,
6: basal anterolateral, 7:mid anterior, 8: mid anteroseptal, 9: mid inferoseptal, 10: mid inferior, 11: mid inferolateral, 12: mid anterolateral, 13: apical anterior, 14: apical septal,
15:apical inferior, 16: apical lateral, 17: apex. The shaded segments: hypertrophied segments. The arrow size is proportionate to electrical forces generated by the corresponding
ventricular walls. A: increased DT ratio Inferior Septum/Lateral wall, B: Increased DT ratio Anterior/Inferior wall.
Fig. 2. Correlation between ECG signs of LV hypertrophy and LVMI.
Fig. 3. Correlation between ECG signs of LV hypertrophy and mean left ventricular
thickness.
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CMR.
5. Study limitations
The main limitation of the present study is the relatively small sam-
ple size of our population. Hence, our study and analysis was based on
small sub-groups of patients, making difﬁcult reaching a deﬁnite con-
clusion. Also, 90% of our patients were in functional class NYHA I\\II,
therefore ECG abnormalities might have different implications in ad-
vanced patients.
6. Conclusion
Our study suggests pathological Q waves in patients with HCM are
not be caused by ﬁbrosis, as in ischemic heart disease, but result from
unbalanced electrical forces generated by asymmetric myocardial hy-
pertrophy. Our study also proposes that ﬁbrosis is the cause of local re-
polarization disturbances, including negative T waves and QT
dispersion.
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